ABCA3 and hemochromatosis type 1: In addition, it has been reported that higher expression of ATP binding cassette transporter 3 (ABCA3) and mutation in HFE gene encoding human hemochromatosis protein both independently predicted resistance to the treatment of fractionated GO plus intensive chemotherapy.